You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 226 ‘Off-the-shelf’ CD19-CAR-T cells generated from umbilical cord blood display superior anti-tumor fitness and lower pro-inflammatory activity as compared to peripheral blood-derived engineered T cells

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Cellular Therapies
226 ‘Off-the-shelf’ CD19-CAR-T cells generated from umbilical cord blood display superior anti-tumor fitness and lower pro-inflammatory activity as compared to peripheral blood-derived engineered T cells

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023218028
Dec 20237006
Jan 20246601
Feb 20245603
Mar 20244002
Apr 20242401
May 20241800
Jun 20243803
Jul 20241402
Aug 2024600
Sep 20242201
Oct 20241203
Nov 20242401
Dec 20241806
Jan 20252006
Feb 20251804
Mar 2025001
Apr 2025002
May 20250015
Jun 2025002
Total664087